Article Category: Duodenal Switch
Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice
GLP-1 agonists have a wide and lasting complication on the GI tract specifically. Some are transient and dose-dependent, and others are long-lasting.
GLP-1 agonists: A review for emergency clinicians
GLP-1 Agosinsts have extensive and complex side effects and complications profile 
This table is from a large review publication for Emergency physicians dealing with the complications of GLP-1 agonist medication.
This table is from a large review publication for Emergency physicians dealing with the complications of GLP-1 agonist medication.Surgical Treatment of Clinically Significant Reactive Hypoglycemia Nesidioblastosis, Post-Gastric Bypass
Date of Publication: March 2021
Duodenal switch operation corrects the complications of gastric bypass.
Vitamin D Toxicity–A Clinical Perspective
Date of Publication: 2018
Vitamin D toxicity is rarely seen. This is even more so in post-weight loss surgical, duodenal switch patients.
Bariatric surgery for type 2 diabetes: Weighing the impact for obese patients
We’d like surgical patients are most effective in treatment of type two diabetes. However different weight loss surgical procedures have different outcomes.
Duodenal Switch Is Superior to Gastric Bypass in Patients with Super Obesity when Evaluated with the Bariatric Analysis and Reporting Outcome System (BAROS)
Duodenal switch operation is superior to gastric bypass for delivering long-term sustained weight loss. However in some patients this may be associated with increased incidence of undesirable side effects.
Duodenal Switch Provides Superior Resolution of Metabolic Comorbidities Independent of Weight Loss in the Super-obese (BMI≥50 kg/m2) Compared with Gastric Bypass
Duodenal switch operation is superior for resolution of metabolic comorbidities in obese patients. The improvement is even more pronounced for those patients with a body mass index over 50. However the difference is noted also for patients for a BMI of less than 50.
Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery
Date of Publication: MArch 2016
Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery
Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007– 2015: A registry-based cohort study
Date of Publication: November 2019
Bariatric surgery is an effective treatment for type 2 diabetes in patients with obesity. Remission of T2D after bariatric surgery was inversely associated with duration of diabetes. Therfore earlier intevention will have the best results.
A systematic review of drug absorption following bariatric surgery and its theoretical implications
Date of Publication: April 2009
A systematic review of drug absorption following bariatric surgery and its theoretical implications
Recent Posts
- A patinet story: Lap Band complication and Wagovy October 24, 2024
- Should Adjustable Gastric Banding (Lap Band) be done? October 6, 2024
- Surgery Bests Lifestyle Changes, GLP-1 for Durable Weight loss September 11, 2024
- Bile Reflux Gastritis August 2, 2024
- Weight loss Medications compared to surgery February 20, 2024